admin India is amongst the top three largest drug producers in the world by volume and the country’s pharmaceuticals market manufactures 60 percent of vaccines globally. Also, its active pharmaceutical ingredients (APIs) market is estimated to attain a revenue of $6 billion by the end of 2020, according to a report on the Indian pharmaceutical industry.
Day by day we see critical impact of innovation in pharmaceutical industry where innovation has dramatically affected the health and wellness of lots of people and the bottom lines of companies that offer it. According to Michael Schuman in The Miracle – The Epic Story of Asia’s Quest for Wealth, Asia’s phenomenal economic growth is attributed to inspiring leaders who were the backbone of the early stages of each Asian economy.
The global evolving economy was hinged on the expansion of the manufacturing industry and the growth of exports. Trailblazers had established a strong presence worldwide and intensified international markets.
The Visionary Leadership Style
Contributing to the nation’s growth, an adroit & tech-veteran Mr. Satish Marukurthi has founded Croissance Clinical Research in 2013. And now the company has become an ISO 9001: 2015 Certified organization with a large network of investigators in public & private hospitals across India and has emerged as a global leader by applying innovative technologies, therapeutic expertise, and commitment to quality to help clients and partners for accelerating the delivery of safe and effective therapeutics.
Being a trailblazer, Satish is leading CCR with his management skills and strong team-building abilities. He believes teamwork is an essential ingredient for the success of organization.
“The world is evolving rapidly with extraordinary digital transformations and we should operate and evolve accordingly. I believe building trust is an essential element to secure the future of the business, “says Satish.
“You need to be smart enough to realize how you achieve things in a shorter amount of time with the right guide and right leadership, “opined Satish. “To lead in the rivalry you require determination, bold thinking, grit to achieve long term goals, and the willingness to adapt. I have been always inspired by the smarter ones who become the guide to help others blaze their trails.”
I strongly believe that to tackle the barriers you need to encourage collaborative, build trust-based relationships, and better equipped to fully engage with your workforce and deliver greater value to their clients” – Satish Marukurthi
Key Values: Collaborative Workplace, Trust, Superior Service Delivery
Mr. Satish Marukurthi, Founder & CEO of Croissance Clinical Research is an endeavoring strategic professional having two decades of an accomplished global career with a successful track record of establishing and growing businesses to a considerable scale. He has been largely involved in building, shaping, and providing innovative strategies for the augmentation of the pharmaceutical industry. His leadership acumen encapsulates almost every business imperatives of organization-people-process-technology nexus associated with running and managing a global business delivery outfit.
Recently, Mr. Satish Marukurthi has been awarded the most prestigious award of the “Pharma Leaders Innovative Leadership in Clinical Research 2019” at Pharma Leaders Power Brand Awards 2019. He is instrumental and playing an active role in the development and growth of the Croissance. He is responsible for managing the business operations of the Croissance and focused on the constant evolution of the organization, client satisfaction, and long-term relationships.
Risk-taker, Satish loves to explore things through opportunities. “We apply our innovative technologies, therapeutic expertise, and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.,” said Satish.
Providing Accurate Clinical Data and Research Information
This midsize Clinical Research Organization (CRO) is providing an extensive range of services in multiple geographic regions and has a diverse and talented team of clinical development professionals who have been exceeding the client’s expectations. The company has been successfully organizing Private and Government centers to conduct clinical trials in the areas of Respiratory, Immunology, Endocrinology, Medical Devices, Ophthalmology, Cardiology, Oncology, Gynecology, Neurology, Pain, inflammation and Dermatology.
Croissance clinical study teams understand the importance of performing accurate feasibility to identify the desired sites and investigators to meet clients challenging expectations and to accomplish this, the team has built a substantial internal database of sites across a broad range of indications and an investigator network of more than 6,000 and have completed 100 studies in just 7 years. Additionally, it provides flexible and accurate data management solutions that ensure integrity, accuracy, reliability, cost-effectiveness, and speed.
Tackling Covid-19 Pandemic
The novel coronavirus (Covid-19) outbreak has been wreaking global havoc over the past few months and continues to affect the residents, families, businesses, and schools all over the world. It has pushed millions of people worldwide into lockdown in their homes, forced many businesses to shut down, and has disastrously increased the death rates.
“I feel the pharma industry is on the front lines of a battle to cover a global pandemic. Setting the right priorities today can help companies accelerate innovation while ensuring a steady supply of urgently needed drugs with the right clinical analysis for patients directly and indirectly affected by Covid-19,” proposed Satish.
“The global Covid-19 pandemic is challenging the human death toll terribly and menacing the world economy. Across industries, companies should act now to protect their employees and clientele—and prepare now for the world beyond coronavirus. It’s becoming imperative to accept the challenge efficiently in COVID-19 through effective health care systems,” suggested Satish. “In 2020, the companies that can protect their people and build more agile practices and teams will create a competitive advantage and advance sooner out of the downturn,” he concluded.
Magazine 
